CryoLife Enters Into Distribution Agreement with Endospan
Vinson & Elkins advised CryoLife, a leading cardiac and vascular surgery company focused on aortic disease, in connection with distribution and credit facility agreements with Endospan, as well as an option agreement to purchase Endospan, an Israeli-based, privately-held developer of NEXUS™, the only endovascular stent graft system approved for the repair of both aneurysms and dissections in the aortic arch.
About Vinson & Elkins
For more than 100 years, Vinson & Elkins has provided deep experience in handling transactions, investments, projects, and disputes worldwide. The firm is a trusted adviser to clients in the most important industrial and digital industries. Learn more by visiting www.velaw.com or follow us on Twitter @VinsonandElkins or connect with us on LinkedIn.
For more information, please speak with our media contacts.